S&P 500   3,012.06 (+0.18%)
DOW   26,918.88 (+0.34%)
QQQ   193.10 (-0.15%)
MSFT   137.59 (-0.61%)
GOOGL   1,245.62 (+0.11%)
AMZN   1,772.44 (-0.74%)
CGC   21.00 (+3.14%)
NVDA   196.43 (+0.21%)
BABA   171.03 (-1.44%)
GE   8.92 (+1.48%)
TSLA   257.57 (+1.61%)
AMD   31.80 (-0.72%)
T   38.32 (+0.24%)
ACB   3.61 (-2.17%)
BAC   31.25 (+0.74%)
GILD   66.45 (+1.90%)
DIS   133.56 (+2.53%)
S&P 500   3,012.06 (+0.18%)
DOW   26,918.88 (+0.34%)
QQQ   193.10 (-0.15%)
MSFT   137.59 (-0.61%)
GOOGL   1,245.62 (+0.11%)
AMZN   1,772.44 (-0.74%)
CGC   21.00 (+3.14%)
NVDA   196.43 (+0.21%)
BABA   171.03 (-1.44%)
GE   8.92 (+1.48%)
TSLA   257.57 (+1.61%)
AMD   31.80 (-0.72%)
T   38.32 (+0.24%)
ACB   3.61 (-2.17%)
BAC   31.25 (+0.74%)
GILD   66.45 (+1.90%)
DIS   133.56 (+2.53%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Amphastar PharmaceuticalsZymeworksY-mAbs TherapeuticsEsperion TherapeuticsAthenex
SymbolNASDAQ:AMPHNYSE:ZYMENASDAQ:YMABNASDAQ:ESPRNASDAQ:ATNX
Price Information
Current Price$20.03$30.89$28.55$39.26$11.31
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$25.05$36.57$39.00$70.44$23.83
% Upside from Price Target25.06% upside18.39% upside36.60% upside79.43% upside110.73% upside
Trade Information
Market Cap$944.13 million$1.16 billion$927.11 million$1.07 billion$741.89 million
Beta1.141.34N/A1.89-0.21
Average Volume171,738279,042120,689337,176757,246
Sales & Book Value
Annual Revenue$294.67 million$53.02 millionN/AN/A$89.10 million
Price / Sales3.2122.90N/AN/A9.81
Cashflow$0.59 per shareN/AN/AN/AN/A
Price / Cash34.13N/AN/AN/AN/A
Book Value$7.90 per share$5.64 per share$4.11 per share$2.95 per share$1.92 per share
Price / Book2.545.48N/AN/A5.89
Profitability
Net Income$-5,740,000.00$-36,560,000.00$-43,270,000.00$-201,810,000.00$-117,440,000.00
EPS$0.21($1.26)($1.50)($7.54)($1.44)
Trailing P/E Ratio95.38N/AN/AN/AN/A
Forward P/E Ratio21.77N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins16.33%-102.78%N/AN/A-161.17%
Return on Equity (ROE)5.52%-24.44%-44.92%-59.62%-85.39%
Return on Assets (ROA)3.92%-19.13%-40.70%-35.60%-45.59%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.13%0.02%0.02%0.01%0.34%
Current Ratio2.81%9.07%9.04%5.65%2.62%
Quick Ratio1.83%9.07%9.04%5.65%2.33%
Ownership Information
Institutional Ownership Percentage47.32%49.87%31.69%N/A48.30%
Insider Ownership Percentage30.80%4.80%38.40%7.70%18.80%
Miscellaneous
Employees2,0781803276575
Shares Outstanding47.23 million39.31 million34.59 million27.17 million77.28 million
Next Earnings Date11/14/2019 (Estimated)11/5/2019 (Estimated)11/12/2019 (Estimated)11/7/2019 (Estimated)11/13/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 Amphastar PharmaceuticalsZymeworksY-mAbs TherapeuticsEsperion TherapeuticsAthenex

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel